KI-Beratung Beta

Produktbild: QSAR Study of Potent Gsk-3¿ Inhibitor for Type II Diabetes
- 13%

QSAR Study of Potent Gsk-3¿ Inhibitor for Type II Diabetes Chemometric analysis based methods for new therapeutic application

13% sparen

31,99 € UVP 37,00 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

This is a best book for analyzing 2D QSAR technique for determining the potent GSK-3beta inhibitor against diabetes.Computer-aided drug design is a branch of medicinal/computational chemistry and is of great interest now a day. Computer-aided design of chemical compounds with controlled properties is...

Beschreibung

This is a best book for analyzing 2D QSAR technique for determining the potent GSK-3beta inhibitor against diabetes.Computer-aided drug design is a branch of medicinal/computational chemistry and is of great interest now a day. Computer-aided design of chemical compounds with controlled properties is generally performed using computer-aided design systems.Its becoming increasingly involved in understanding the differences between potent molecules and drug candidates (ADMET-absorption, distribution, metabolism, excretion and toxicity) this is already fueling a rise in impact and expectations for CADD. The use of quantitative structure-activity relationships (QSAR) has become increasingly helpful in understanding many aspects of chemical-biological interactions in drug and other scientific research. In the present effort, we exaggerate our pursuit of being establishing the relationship between the various physiochemical parameters and anti-diabetic activity of 3-aryl- 4-(arylhydrazono)-1H pyrazol-5-ones derivatives by using classical quantitative structure- activity relationship (QSAR) descriptors and similarity indices.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.02.2017

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

64

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.02.2017

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

64

Maße (L/B/H)

22/15/0,5 cm

Gewicht

113 g

Sprache

Englisch

ISBN

978-3-330-04043-4

Herstelleradresse


Email: info@bod.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: QSAR Study of Potent Gsk-3¿ Inhibitor for Type II Diabetes